| Literature DB >> 22303339 |
Zhi-Liang Hu1, Antonio M Ramos, Sean J Humphray, Jane Rogers, James M Reecy, Max F Rothschild.
Abstract
The newly available pig genome sequence has provided new information to fine map quantitative trait loci (QTL) in order to eventually identify causal variants. With targeted genomic sequencing efforts, we were able to obtain high quality BAC sequences that cover a region on pig chromosome 17 where a number of meat quality QTL have been previously discovered. Sequences from 70 BAC clones were assembled to form an 8-Mbp contig. Subsequently, we successfully mapped five previously identified QTL, three for meat color and two for lactate related traits, to the contig. With an additional 25 genetic markers that were identified by sequence comparison, we were able to carry out further linkage disequilibrium analysis to narrow down the genomic locations of these QTL, which allowed identification of the chromosomal regions that likely contain the causative variants. This research has provided one practical approach to combine genetic and molecular information for QTL mining.Entities:
Keywords: integrated analysis; meat quality QTL; pig chromosome 17
Year: 2011 PMID: 22303339 PMCID: PMC3268380 DOI: 10.3389/fgene.2011.00043
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Figure 1. QTL position estimates for color, 48 h Minolta L score (LABLM) and 48 h Hunter L score (LABLH) are shown. The 1 and 5% chromosome-wide significance levels were estimated to be 7.08 (solid line) and 5.38 (dashed line) respectively, while the 1 and 5% genome-wide significance levels used were 9.96 and 8.22 respectively.
Figure 2. QTL position estimates for average drip percentage (AVDRIP), average lactate (AVLAC), and average glycolytic potential (AVGP) are shown. The 1 and 5% chromosome-wide significance levels were estimated to be 7.08 (solid line) and 5.38 (dashed line) respectively, while the 1 and 5% genome-wide significance levels used were 9.96 and 8.22 respectively.
Figure 3Log likelihood profiles of the QTL segment mapping analysis with QXPAK for 48 h Minolta L score (LABLM), 48 h Hunter L score (LABLH), color, average lactate (AVLAC), and average glycolytic potential (AVGP). Shown on the x axis are the chromosomal segments, each is flanked with 2 markers: 1 (SW335 – SWR1004); 2 (SWR1004 – SW2441); 3 (SW2441 – SIGLEC1); 4 (SIGLEC1 – MYLK2); 5 (MYLK2 – ASIP); 6 (ASIP – S0292); 7 (S0292 – S0359); 8 (S0359 – PKIG); 9 (PKIG – MMP9); 10 (MMP9 – PTPN1); 11 (PTPN1 – ATP9A); 12 (ATP9A – CYP24A1); 13 (CYP24A1 – MC3R/DOK5); 14 (MC3R/DOK5 – AURKA); 15 (AURKA – CSTF1); 16 (CSTF1 – C20orf43); 17 (C20orf43 – PigE-90F2); 18 (PigE-90F2 – S0332); 19 (S0332 – RPCI44-326L12); 20 (RPCI44-326L12 – RPCI44-332L18); 21 (RPCI44-332L18 – SPO11); 22 (SPO11 – RAE1); 23 (RAE1 – PCK1); 24 (PCK1 – RAB22A); 25 (RAB22A – RPCI44-431M20); 26 (RPCI44-431M20 – GNAS); 27 (GNAS – CTSZ); 28 (CTSZ – CH242-247L10); 29 (CH242-247L10 – SW2431); 30 (SW2431 – PPP1R3D); 31 (PPP1R3D – SW2427). The y axis shows the log likelihood values.
Least-squares means and SE for the association analysis of 12 markers with meat color traits [color score; 48 h Minolta L score (LABLM); and 48 h Hunter L score (LABLH)] in F2 Berkshire × Yorkshire population.
| Color | LABLM | LABLH | ||
|---|---|---|---|---|
| 11 | 69 | 3.17 ± 0.06c | 22.40 ± 0.41c | 47.29 ± 0.43a |
| 12 | 217 | 3.22 ± 0.04c | 22.49 ± 0.27e | 47.37 ± 0.28e |
| 22 | 214 | 3.31 ± 0.04d | 21.51 ± 0.27d,f | 46.43 ± 0.29b,f |
| 11 | 20 | 3.23 ± 0.11e | 21.72 ± 0.72e,f | 46.59 ± 0.75e,f |
| 12 | 164 | 3.16 ± 0.04e | 22.75 ± 0.29e | 47.68 ± 0.31e |
| 22 | 324 | 3.30 ± 0.03f | 21.74 ± 0.24f | 46.62 ± 0.25f |
| 11 | 275 | 3.30 ± 0.03c | 21.68 ± 0.26e | 46.60 ± 0.28e |
| 12 | 191 | 3.18 ± 0.04d | 22.62 ± 0.29f | 47.48 ± 0.31f |
| 22 | 36 | 3.25 ± 0.09c,d | 22.18 ± 0.57e,f | 47.09 ± 0.60e,f |
| 11 | 285 | 3.28 ± 0.03a | 21.61 ± 0.26e | 46.54 ± 0.27c,e |
| 12 | 179 | 3.24 ± 0.04a,b | 22.47 ± 0.29f | 47.31 ± 0.31d |
| 22 | 43 | 3.14 ± 0.08b | 23.20 ± 0.51f | 48.15 ± 0.54f |
| 11 | 184 | 3.30 ± 0.04a | 21.62 ± 0.27c | 46.47 ± 0.28c |
| 12 | 240 | 3.21 ± 0.03b | 22.33 ± 0.25d | 47.23 ± 0.26d |
| 22 | 56 | 3.24 ± 0.07a,b | 22.58 ± 0.45d | 47.51 ± 0.47d |
| 11 | 260 | 3.31 ± 0.03e,c | 21.65 ± 0.24a,e | 46.54 ± 0.26e |
| 12 | 206 | 3.19 ± 0.04f | 22.54 ± 0.27f | 47.43 ± 0.29f |
| 22 | 35 | 3.11 ± 0.08d | 22.60 ± 0.56b | 47.47 ± 0.58f |
| 11 | 248 | 3.32 ± 0.03e,c | 21.56 ± 0.24e,c | 46.46 ± 0.26e,c |
| 12 | 218 | 3.19 ± 0.040f | 22.57 ± 0.26f | 47.46 ± 0.28f |
| 22 | 36 | 3.11 ± 0.08d | 22.74 ± 0.54d | 47.63 ± 0.56d |
| 11 | 333 | 3.30 ± 0.03c | 21.71 ± 0.23e | 46.65 ± 0.25e |
| 12 | 157 | 3.18 ± 0.04d | 22.66 ± 0.30f | 47.54 ± 0.32f |
| 11 | 87 | 3.11 ± 0.05e,c | 22.91 ± 0.39c,e | 47.83 ± 0.41c,e |
| 12 | 289 | 3.29 ± 0.03f | 22.01 ± 0.26d | 46.90 ± 0.28d |
| 22 | 130 | 3.26 ± 0.05d | 21.54 ± 0.34f | 46.44 ± 0.36f |
| 11 | 88 | 3.11 ± 0.05e,c | 22.88 ± 0.38c,e | 47.81 ± 0.41c,e |
| 12 | 292 | 3.29 ± 0.03f | 22.00 ± 0.25d | 46.90 ± 0.27d |
| 22 | 124 | 3.26 ± 0.05d | 21.60 ± 0.35f | 46.50 ± 0.37f |
| 11 | 50 | 3.07 ± 0.07c,e | 23.10 ± 0.47e | 47.99 ± 0.50e |
| 12 | 208 | 3.22 ± 0.04d,a | 22.37 ± 0.27c | 47.25 ± 0.29c |
| 22 | 248 | 3.31 ± 0.03f,b | 21.62 ± 0.25f,d | 46.52 ± 0.27f,d |
| 11 | 87 | 3.26 ± 0.05c | 21.44 ± 0.34e | 46.34 ± 0.36e |
| 12 | 289 | 3.29 ± 0.03e | 22.00 ± 0.26e | 46.89 ± 0.28e |
| 22 | 130 | 3.12 ± 0.05d,f | 23.06 ± 0.36f | 48.00 ± 0.39f |
.
| Marker | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Linkage map location (cM) | 80.6 | 83.7 | 85.7 | 87.7 | 87.7 | 88.6 | 90.6 | 92 | 92.4 | 93.5 |
| Sequence map location (kb) | 192–261a | 1,111–1,247 | 3,318–3,339 | 3,600–3,751 | 5,077–5,078 | 5,151–5,162 | 5,164–5,183 | 5,164–5,183 | 5,181–5,193 | 5,200–5,240 |
| SNP type | Exonic (S)b | Intronic | Exonic (S) | Intronic | Exonic (S) | Intronic | Exonic (S) | Exonic (NS)b | Exonic (S) | Exonic (NS) |
| A.A. change | n.a.c | n.a.c | n.a.c | n.a.c | n.a.c | n.a.c | n.a. | Leu to Pro | n.a.c | His to Arg |
| Allele 1 freq. | ||||||||||
| Berkshire | 0.75 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
| Yorkshire | 1 | 0.78 | 0.56 | 0.61 | 0.78 | 0.11 | 0.78 | 0.89 | 0.78 | 0.33 |
| Marker | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Linkage map location(cM) | 95 | 95 | 95 | 96 | 97.7 | 99.4 | 101.1 | 103.3 | 104.6 | 107.5 |
| Sequence map location (kb) | 5,250–5,294 | 5,296–5,298 | 5,420 | 5,561 | 5,616 | 5,794–5,886 | 5,953 | 5,940–5,955 | 5,961–5,977 | 6,140–6,146 |
| SNP type | Intronic | Intronic | n.a.d | n.a.d | n.a.d | Exonic (S) | Intronic | Intronic | Intronic | Exonic (NS) |
| A.A. change | n.a.c | n.a.c | n.a.c | n.a.c | n.a.c | n.a.c | n.a.c | n.a.c | n.a.c | Ile to Val |
| Allele 1 freq. | ||||||||||
| Berkshire | 0 | 0 | 0.75 | 1 | 1 | 0 | 0 | 1 | 0 | |
| Yorkshire | 0.17 | 0.17 | 0.44 | 0.61 | 0.39 | 0.61 | 0.61 | 0.39 | 0.72 |
| Marker | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Linkage map location(cM) | 110.2 | 111.1 | 111.6 | 113.2 | 113.8 | 114.8 | 115.6 | 115.6 | 116.4 | 119.2 |
| Sequence map location(kb) | 6,644–6,665 | 6,721–6,779 | 6,800–6,850 | 7,110 | 7,056–7,123 | 7,212–7,220 | 7,278 | 7,384–7,452 | 7,578 | n.a. |
| SNP type | Exonic (NS) | Intronic | Exonic (NS) | Intronic | Intronic | Exonic (NS) | n.a.d | Exonic (NS) | n.a.d | Exonic (S) |
| A.A. change | Cys to Arg | n.a.c | Pro to Leu | n.a.c | n.a.c | Lys to Arg | n.a.c | Arg to Cys | n.a.c | n.a.c |
| Allele 1 freq. | ||||||||||
| Berkshire | 1 | 1 | 1 | 0.25 | 0.25 | 0 | 0.25 | 0 | 0 | |
| Yorkshire | 0.44 | 0.44 | 0.67 | 0.78 | 0.78 | 0.72 | 0.78 | 0.22 | 0.22 |
.
| Trait | 11 | 12 | 11 | 12 | 12 | 22 | 11 | 12 | 22 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 352 | 145 | 433 | 70 | 47 | 457 | 69 | 217 | 214 | |||||
| AVGP | 0.059 | 105.73 ± 1.16a | 102.63 ± 1.58b | 0.038 | 105.71 ± 1.06c | 101.23 ± 2.14d | 0.019 | 99.46 ± 2.51c | 105.40 ± 1.01d | 0.056 | 105.78 ± 2.07c,d | 106.58 ± 1.28c | 103.00 ± 1.29d |
| AVLAC | 0.091 | 87.91 ± 0.87a | 85.76 ± 1.20b | 0.089 | 87.83 ± 0.81a | 84.96 ± 1.66b | 0.089 | 84.22 ± 1.97a | 87.58 ± 0.80b | 0.036 | 88.41 ± 1.61c,d | 88.66 ± 0.99c | 85.72 ± 0.99d |
| Trait | 11 | 12 | 11 | 12 | 12 | 22 | 11 | 12 | 22 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 451 | 50 | 427 | 65 | 65 | 439 | 285 | 179 | 43 | |||||
| AVGP | 0.029 | 105.42 ± 1.02c | 100.04 ± 2.45d | 0.018 | 105.43 ± 1.08c | 100.12 ± 2.22d | 0.043 | 100.87 ± 2.20c | 105.41 ± 1.04d | 0.072 | 103.65 ± 1.24c | 107.20 ± 1.44d | 104.01 ± 2.58c,d |
| AVLAC | 0.097 | 87.64 ± 0.79a | 84.45 ± 1.91b | 0.045 | 87.56 ± 0.82c | 84.09 ± 1.72d | 0.167 | 85.16 ± 1.71 | 87.57 ± 0.80 | 0.054 | 86.09 ± 0.96c | 89.06 ± 1.12d | 88.27 ± 2.01c,d |
.
Experimental information of the gene markers mapped to SSC17.
| Gene | Primer sequence (5′–3′) | Fragment size (bp) | Annealing temp. (°C) | SNP location | Restriction enzyme | Allele sizes (bp) |
|---|---|---|---|---|---|---|
| F: ATAGCCACACGGTCTCTTCG | 257 | 60 | 3 | 209, 48 (allele 1) | ||
| R: TGCTGCTTGTTTTGTCTGAT | 159, 50, 48 (allele 2) | |||||
| F: ACGTCCAGACTATGTCCCCA | 369 | 59 | Exon 3 | 251, 118 (allele 1) | ||
| R: CTGTGCGGTCTCGTTCATC | 165, 118, 86 (allele 2) | |||||
| F: GGATGGAAACGCTACGGTTA | 456 | 60 | Exon 4 | 384, 65, 7 (allele 1) | ||
| R: GGAGCAGACTTTGGGTTGTT | 313, 71, 65, 7 (allele 2) | |||||
| F: AGGAAATGAGGTGAAAGAGCA | 464 | 57 | Exon 3 | 464 (allele 1) | ||
| R: GTGGGTCAGGGAACTCGTAG | 317, 147 (allele 2) | |||||
| F: CTGGGGCTTTATGTCACCAC | 470 | 54 | Intron 8 | 236, 165, 69 (allele 1) | ||
| R: ACCACAGAGCATTCCAAACA | 236, 143, 69 (allele 2) | |||||
| F: GTGCTGGAGCCCGCTTCT | 120 | 60 | Intron 1 | 120 (allele 1) | ||
| R: CACCAGGACTTTGCTCCTGT | 97, 23 (allele 2) | |||||
| F: TTTATGGCACCGTTTCTACG | 529 | 61 | Exon 4 | 394, 80, 55 (allele 1) | ||
| R: GGGAGTTTCCTCTCTGTGG | 256, 138, 80, 55 (allele 2) | |||||
| F: CATCTGAAGTAGGTTCTCACAAAA | 422 | 60 | Exon 10 | n.a. | n.a. | |
| R: ACCCGCACACCGCTCCTC | ||||||
| F: ACGAAGCAGAAAGCCCAGT | 633 | 59 | Exon 6 | 637 (allele 1) | ||
| R: GAGGAAGAGTGGCGTGTTTT | 507, 130 (allele 2) | |||||
| F: TTTTCCAAGCCCAGTCTCAC | 617 | 63 | Exon 3 | 323, 149, 145 (allele 1) | ||
| R: CTGCCGCCTTCTCAACAC | 233, 149, 145, 90 (allele 2) |
aThe genes mapped included chromosome 20 open reading frame 108 (C20orf108), cleavage stimulation factor, 3′ pre-RNA, subunit 1, 50kDa (CSTF1), aurora kinase A (AURKA), chromosome 20 open reading frame 32 (C20orf32), chromosome 20 open reading frame 43 (C20orf43), chromosome 20 open reading frame 106 (C20orf106), bone morphogenetic protein 7 (BMP7), protein phosphatase 4, regulatory subunit 1-like (PPP4R1L), VAMP (vesicle-associated membrane protein)-associated protein B and C (VAPB) and chromosome 20 open reading frame 174 (C20orf174).
bThe SNP detected on PPP4R1L exon 10 was not within a restriction enzyme recognition site. This marker was genotyped by sequencing individuals in the entire BY pedigree.